Group Fitness for Schizophrenia Spectrum Disorder (SSD)

Schizophrenia is a chronic mental health problem that impacts individuals and their families. It is characterized by thought disorder, severe negative symptoms, and impaired social functioning.

Acute exacerbations of the condition often require prompt medical attention and admission to hospital. Treatment usually consists of a combination of antipsychotic medication, anticonvulsants, antidepressants and at least one mood stabilizing medication. In some cases, benzodiazepines may be required. In other cases, more aggressive measures, such as electroconvulsive therapy (ECT), may be necessary. Where treatment is based on the severity of symptoms, it typically involves the patient being transferred from one psychiatric facility to another. The treatment of chronic cases usually involves the use of conventional antipsychotic medications. Other non-drug treatments include cognitive behaviour therapy and family support.

Schizophrenia cannot be cured, as the condition is a psychological one. However, with good treatment, symptoms can be eliminated, and for many patients, they can live reasonably normal lives.

The exact cause of schizophrenia remains unknown, but it is likely a combination of factors which present in the womb or early development. These factors include genetics, brain injury, and exposure to certain toxins during pregnancy.

Psychoses can be divided into two major subgroups: negative symptoms and positive symptoms. Negative symptoms include apathy, avolition, alogia, anhedonia, asociality and blunted affect. Positive symptoms include perceptual distortions, auditory and tactile hallucinations, delusions, disorganized speech, thought disorder and inappropriate behaviors. These symptoms may reflect a combination of both the cognitive and affective functions on the one hand and the neuropathological brain processes on the other.

Over 5 million people in the United States are affected by the illness each year. In the first instance, schizophrenia is one of the most disabling chronic neurological disorders in the world.

The majority of this study’s patients felt that general nutrition education was safe for people with schizophrenia. Results from a recent clinical trial provides strong evidence for the continued availability, and, where appropriate, escalation of this type of education among people with a schizophrenia spectrum diagnosis.

We are still in the early part of discovering treatments for this challenging mental illnesses like schizophrenia but in the foreseeable future we may have some cures for it in the making (or in the past)

Average age of symptoms onset is relatively young, about 19 years old. When you do research with schizophrenia, you will always find this is a common misconception of the average age of clinical onset. Which is a very important thing when the disease can come and go in the lifetime.\n

More research is needed to understand the complexity; therefore, it remains challenging to develop effective interventions for schizophrenia for patients and their families. Research for schizophrenia is being carried out at the level of individuals, families and community.\n\n- Schizophrenia"

"Chinhoscelis\n\nChinhoscelis is a genus of mites in the family Acaridae.

Nutritional education, if not integrated into comprehensive mental health services, remains confined to simplistic messages regarding the healthy diet. More in-depth education about the link between diet and mental illness and education on the role of nutritional disorders is warranted.